Skip to content

Soft Coagulation for the Prevention of Adenoma Recurrence

Soft Coagulation for the Prevention of Adenoma Recurrence After Endoscopic Mucosal Resection (EMR) of Large Sessile Colonic Polyps: A Multicentre, Randomized Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01789749
Acronym
SCAR
Enrollment
455
Registered
2013-02-12
Start date
2013-07-31
Completion date
2016-12-16
Last updated
2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Adenomas

Keywords

snare tip soft coagulation, endoscopic mucosal resection, adenoma recurrence, adenoma, colonoscopy

Brief summary

Recurrence after endoscopic mucosal resection of laterally spreading lesions (LSL) \>= 20mm in size occurs in approximately 20% of cases at surveillance colonoscopy. We aim to evaluate the efficacy of prophylactic adjuvant thermal ablation of the EMR mucosal defect margin in reducing adenoma recurrence following colonic EMR.

Interventions

OTHERNo Snare Tip Soft Coagulation

Sponsors

Professor Michael Bourke
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Patients were blinded to the treatment allocation. The endoscopists performing the index and surveillance procedures were not blinded to the treatment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Referred for removal of a colonic polyp \>= 20mm in size * Able to give informed consent to involvement in trial

Exclusion criteria

* Younger than 18 years of age * Highly dependant on medical care * Women who are pregnant or may be pregnant. * Taken clopidogrel within 7 days * Taken warfarin within 5 days * Had full therapeutic dose unfractionated heparin within 6 hours * Had full therapeutic dose low molecular weight heparin (LMWH) within 12 hours * Known clotting disorder * Previous attempt at EMR of the polyp referred for resection * Polyp located at the ileo-caecal valve, appendiceal orifice * Fully circumferential polyp * Incomplete snare resection of the polyp

Design outcomes

Primary

MeasureTime frameDescription
Endoscopic recurrence4-6 months and 18 monthsPresence of residual/recurrent adenoma at the EMR scar at endoscopic follow-up

Secondary

MeasureTime frameDescription
En bloc resectionIndex procedureRate of 'en bloc resection' (removing entire lesion in one snare) with histologically confirmed clear margins
Snare resectionsIndex procedureThe number of snare resections needed to achieve complete clearance
DurationIndex procedureTime required for EMR
Perforation during EMRDuring index procedurePerforation during EMR
Post EMR bleedingPost Index procedureBleeding after EMR requiring admission or repeat intervention
Histologic recurrence4-6 months and 18 monthsPresence of residual/recurrent adenoma on biopsy of the endoscopic resection scar
Location of bleeding vesselsIndex procedure, if post EMR bleedingLocation of bleeding vessels
Size/number of bleeding vesselsIndex procedure, if post EMR bleedingSize/number of bleeding vessels
Delayed perforationAfter index procedureDelayed perforation requiring intervention or readmission
ReadmissionAfter index procedureReadmission after index procedure
Number of injections for hemostasisIndex procedure, if post EMR bleedingNumber of injections required for haemostasis

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026